Early diagnosis of secondary progressive multiple sclerosis: focus on fluid and neurophysiological biomarkers-Reference-Cited by-同舟云学术

Early diagnosis of secondary progressive multiple sclerosis: focus on fluid and neurophysiological biomarkers

Published:2020-06-05 Issue:10 Volume:268 Page:3626-3645
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Ferrazzano Gina,Crisafulli Sebastiano Giuseppe,Baione Viola,Tartaglia Matteo,Cortese Antonio,Frontoni Marco,Altieri Marta,Pauri Flavia,Millefiorini Enrico,Conte Antonella^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

https://link.springer.com/content/pdf/10.1007/s00415-020-09964-4.pdf

Reference97 articles.

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343(13):938–952. https://doi.org/10.1056/nejm200009283431307

2. Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sorensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stuve O, Waubant E, Polman CH (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83(3):278–286. https://doi.org/10.1212/wnl.0000000000000560

3. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintore M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162–173. https://doi.org/10.1016/s1474-4422(17)30470-2

4. Inojosa H, Proschmann U, Akgun K, Ziemssen T (2019) A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition. J Neurol. https://doi.org/10.1007/s00415-019-09489-5

5. Scalfari A, Neuhaus A, Daumer M, Muraro PA, Ebers GC (2014) Onset of secondary progressive phase and long-term evolution of multiple sclerosis. J Neurol Neurosurg Psychiatry 85(1):67–75. https://doi.org/10.1136/jnnp-2012-304333

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Faces of “Too Late”—A Surprisingly Progressive Cohort of “Stable” Relapsing Remitting Multiple Sclerosis Patients;Medicina;2024-08-26

2. Biomarkers Differentiating RRMS and SPMS in Multiple Sclerosis—A Systematic Review;Sclerosis;2024-07-31

3. Real-World Study of Serum Neurofilament Light Chain Levels in Ocrelizumab-Treated People with Relapsing Multiple Sclerosis;Journal of Personalized Medicine;2024-06-27

4. Multiple sclerosis: modern diagnostic markers and prognostic factors of disease progression;Сибирский научный медицинский журнал;2024-03-06

5. The glymphatic system as a potential biomarker and therapeutic target in secondary progressive multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-03